NANDA VENU
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology SEATTLE, WA NPI 1013135912
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology WA VERTEX PHARMACEUTICALS INCORPORATED All categories
General Payments — all program years on this page
$1,417.81
- Category: General Payments
- Program years: PY2018–2023
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $950.67 across 4 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $866.67 | 2 |
| Food and Beverage | $84.00 | 2 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | $866.67 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $84.00 | 2 |
By program year
Records — PY2023 (4)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1013448091 | Vertex Pharmaceuticals Incorporated | $500.00 | 12/12/2023 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1013448121 | Vertex Pharmaceuticals Incorporated | $366.67 | 10/12/2023 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1055652049 | Takeda Pharmaceuticals U.S.A., Inc. | $15.75 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1055652057 | Takeda Pharmaceuticals U.S.A., Inc. | $68.25 | 05/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.